NCT05364658View on ClinicalTrials.gov

A Clinical Evaluation of the LensGen Intraocular Lens

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

November 18, 2018

Primary Completion Date

November 30, 2019

Study Completion Date

January 30, 2020

Conditions
CataractPresbyopia
Interventions
DEVICE

Juvene IOL

Indicated for Implantation in the human eye after removal of a cataractous crystalline lens

Trial Locations (2)

22010

Centro Oftamologico de Tijuana, Tijuana

64060

Dr. Enrique Barragan Oftalmologico, Monterrey

All Listed Sponsors
lead

LensGen, Inc.

INDUSTRY

NCT05364658 - A Clinical Evaluation of the LensGen Intraocular Lens | Biotech Hunter | Biotech Hunter